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LETTERS TO THE EDITOR
All Allusions to the Great War Aside . . .
All allusions to the Great War aside, Miller (1) defends the value
of perfusion scintigraphy for risk stratification in patients with
coronary artery disease (CAD) in an editorial comment on the
Intermediate Lesions: Intracoronary Flow Assessment versus
99mTc-MIBI SPECT (ILIAS) study. The ILIAS was a Dutch
multicenter study designed as a direct comparison between perfu-
sion scintigraphy and intracoronary Doppler flow measurements
for clinical decision making in patients with intermediate coronary
lesions in the presence of multivessel disease (2). The patients were
included following a diagnostic catheterization that documented
multivessel CAD with one severe coronary narrowing, eligible for
percutaneous transluminal coronary angioplasty (PTCA), and one
intermediate lesion. A perfusion scintigraphy stress test was
considered mandatory for evaluation of the intermediate lesion in
those patients already scheduled for PTCA of the severe coronary
narrowing.
The results of the ILIAS trial show that it is safe to defer an
angioplasty of the intermediate lesions if the coronary flow velocity
reserve is above 2.0. This finding accords with previous small-sized
single-center experiences. Moreover, the Doppler flow measure-
ments appeared to be a better predictor for the occurrence of major
adverse cardiac events (i.e., the need for coronary revascularization)
related to the intermediate lesion than perfusion scintigraphy. This
latter finding is relevant for daily clinical practice in interventional
cardiology concerning decision making in intermediate coronary
narrowings. It may avoid the need for additional scintigraphic
stress testing following diagnostic procedures and facilitates ad hoc
PTCA.
Miller’s editorial (1) underscores the contribution of perfusion
scintigraphy for risk stratification in patients with CAD—that is,
patients with large-sized perfusion defects have a worse clinical
outcome compared to patients with smaller-sized perfusion defects
(3). These studies indicated that global assessment of myocardial
perfusion yields prognostic information. However, this is not in
contrast with the findings of the ILIAS trial, which demon-
strated the value of intracoronary physiologic parameters for
evaluation of regional myocardial perfusion (2). This latter
finding relates presumably to the difficulty to allocate reversible
perfusion defects to vascular territories, whereas intracoronary
measurements allow selective evaluation distal to coronary
narrowings. Miller’s conclusion (1) is correct, namely that it
would have been a physiological bridge too far if the contribu-
tion of intracoronary evaluation of coronary narrowings mea-
surements was interpreted to replace perfusion scintigraphy for
risk stratification. The ILIAS trial provides complementary
information relevant for clinical decision making in patients
already scheduled for cardiac catheterization. The contribution
of intracoronary physiologic testing should be considered as a
bridge (rather than a bridge too far) between noninvasive stress
testing providing prognostic information in patients with mul-
tivessel disease, and appropriate use of percutaneous interven-
tions based on accurate invasive evaluation of regional myocar-
dial perfusion.
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Coronary Microvascular Spasm in
Patients With Vasospastic Angina
I read with interest the study by Sun et al. (1), which showed that
25.5% of patients with vasospastic angina developed myocardial
ischemia with submaximal doses of intracoronary acetylcholine;
angina was unassociated with spasm of epicardial arteries and was
attributed to microvascular spasm. Remaining patients developed
myocardial ischemia only when epicardial spasm occurred, and Sun
et al. (1) did not rule out the coexistence of microvascular spasm in
these cases.
The Sun et al. (1) study is in keeping with the spasm of
resistance vessel (S-RV) concept of ischemic heart disease (IHD)
(2–5), which asserts that S-RV induces symptoms in all syndromes
of IHD and in cases with and without coronary artery disease
(CAD). S-RV is used instead of microvascular spasm, as spasm
probably occurs in vessels designed to undergo vasomotion to
maintain vascular homeostasis. The concept asserts that risk factors
act additively and operate by favoring S-RV, and there is evidence
that major risk factors favor S-RV—including hypercholesterol-
emia and CAD (2,4,5). The concept avers that stenotic CAD
favors S-RV through ischemia-induced S-RV, and there is abun-
dant evidence that significant ischemia favors S-RV (2,5). As an
example, effort angina is attributed to stenotic CAD plus exertion,
which together cause sufficient ischemia to trigger ischemia-
induced S-RV and clinical symptoms.
Interest in S-RV in IHD has been limited mainly to vasospastic
angina, as these cases are unassociated with stenotic CAD. But
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